ACTRN12610000639022尚未招募不适用
A prospective, open-label, contralateral daily wear, cross over, randomised clinical trial assessing the effect of wearing a novel and five commercially available contact lenses for 1 week on corneal topography worn in experienced myopic contact lens wearers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years(—)
- 性别
- All
入选标准
- •be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent. If participant is a child or adolescent, a parent or legal guardian must be able to provide this consent,
- •- be between the ages of 18 and 45 years old inclusive
- •- be myopic (short sighted) -0.75D to -4.25D with astigmatism no more than -1.00 D
- •- be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
- •- have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses;
- •- have vision correctable to at least 6/12 (20/40) or better in each eye with contact lenses.
- •- be experienced wearing contact lenses
排除标准
- •- Pre-existing ocular irritation that would preclude contact lens fitting;
- •- Strabismus or amblyopia;
- •- Any ocular condition that may preclude safe wearing of contact lenses (e.g. active corneal infection, severe dry eye, reduced corneal sensitivity, exophthalmos/lagophthalmos, facial nerve palsy);
- •- Active corneal infection (bacterial, viral, fungal or protozoan) or any active ocular disease such as iritis, corneal oedema or corneal dystrophies, including anterior membrane dystrophy that would affect wearing of contact lenses;
- •- Any systemic disease that may adversely affect ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankolysing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
- •- Eye surgery within 12 weeks immediately prior to enrolment for this trial;
- •- Previous corneal refractive surgery;
- •- Any ocular injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would affect the wearing of contact lenses;
- •- Contraindications to hydrogel contact lens wear;
- •- Worn orthokeratology lenses within the past 3 months;
- •- Currently enrolled in another clinical trial;
- •- Pregnancy (verbal report from participant will suffice).
研究者
相似试验
进行中(未招募)
1 期
A twenty-four week, open-label, non-comparative, multicenter study to assess the efficacy and tolerability of an aliskiren-based treatment algorithm in patients with mild to moderate hypertension.hypertensionEUCTR2008-002797-36-SKovartis Pharma Services AG230
进行中(未招募)
不适用
A twenty-four week, open-label, non-comparative, multicenter study to assess the efficacy and tolerability of an aliskiren-based treatment algorithm in patients with mild to moderate hypertension.MedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionhypertensionEUCTR2008-002797-36-FRovartis Pharma Services AG230
进行中(未招募)
不适用
A twenty-four week, open-label, non-comparative, multicenter study to assess the efficacy and tolerability of an aliskiren-based treatment algorithm in patients with mild to moderate hypertension.hypertensionEUCTR2008-002797-36-HUovartis Pharma Services AG230
已完成
3 期
A prospective, open-label, daily wear, parallel group, randomised clinical trial assessing an investigational contact lens care solution for comfort, safety and efficacy with four commercially available contact lenses, worn bilaterally over three months, in both experienced and new contact lens wearersACTRN12609000640202Abbott Medical Optics, Inc160
进行中(未招募)
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 16 years with bladder overactivity caused by a neurological condition (such as spina bifida).eurogenic Detrusor Overactivity (NDO).MedDRA version: 20.0 Level: PT Classification code 10029279 Term: Neurogenic bladder System Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022475-55-BEPfizer Inc.235 East 42nd Street, New York, NY 10017186
